As expected, none of the tumors tested showed nuclear immunostaining for WT1, except for Wilms’ tumors (three out of three cases) in both epithelial and blastemal component, in addition to a cytoplasmic immunostaining. This evidence concerns the gene WT1 and Nephroblastoma.